BioSpace News Archive

First iTind Procedures to Relieve Symptoms of Enlarged Prostate, without Compromise to Sexual Function, Are Performed; iTind Procedure Also Receives Medicare Outpatient Billing Codes for Reimbursement

Immunovia AB (publ) (“Immunovia”) announced today that Immunovia’s Chief Executive Officer, Patrik Dahlen, has acquired Immunovia 15,000 shares for 2.5 MSEK on the open market and his total holding is now 45,000 shares.

Augmedix, Inc., the ambient, mobile, real-time, and remote documentation specialist for doctors and health systems, yesterday announced financial results for its third quarter ended September 30, 2020.

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced a poster presentation at the Association for Molecular Pathology (AMP) 2020 Annual Meeting & Expo.

Ivantis’ Commitment to Scientific Rigor Earns Primary Open-Angle Glaucoma Preferred Practice Pattern Designation and Fifth Publication in the Journal Ophthalmology

Scilligence, a provider of web-based informatics solutions for R&D, has partnered with CAS, a division of the American Chemical Society, to enable direct access to CAS scientific content through the Scilligence informatics platform.

Abzyme Therapeutics LLC, a biotech company focused on developing antibodies for diagnostic and therapeutic applications, has filed a patent application entitled “Antibodies Binding to Human CD3 at Acidic pH”, USPTO number 63/109,005. This patent application is an important step forward for Abzyme Therapeutics solidifying its intellectual property position in the field of therapeutic antibody development. Monoclon

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for long-acting, injectable cabotegravir for HIV pre-exposure prophylaxis (PrEP). The Breakthrough Therapy Designation was based on efficacy and safety results from HP

Today the Lung Cancer Research Foundation® (LCRF) announced the awardees of its 2020 Scientific Grant Program during its 15th Anniversary Virtual Celebration.

Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the Company will participate in the upcoming Piper Virtual Healthcare Conference